IN FORCE Norms Committee — Pharmaceuticals (NC-III) Advance Authorisation 2023-04-28

DGFT Committee Minutes

Document text

Government of IndiaMinistryofCommerceandIndustry Department of Commerce DIRECTORATE GENERAL OF FOREIGN TRADE

Minutes of the Norms Committee – 3 Meeting No. NC/3/MEET/Apr/202324/01 dated 28/04/2023 under the Chairmanship of Shri Rajiv Kumar Soni, Jt. DGFT for considering the cases/issues under Duty Exemption Scheme (Chapter-4) of Foreign Trade Policy, 2015-20 pertaining to Chemical and Allied products falling under Chapter 29 and 30.

Following members were present in the Meeting:

S.N. Name & Designation Department
1 Shri Shaish Kumar, Technical Consultant
2 Shri D.N. Mathur, Technical Consultant
3 Shri Nand Lal, Technical Consultant
In attendance
1 Shri T. Songzalian, Deputy DGFT DGFT
  1. The Norms Committee has taken decision only with respect to technical aspect/ wastage norms. While redeeming the application, RAs should check that the applicant has fulfilled all requirements as prescribed in policy/procedure including those in policy circulars issued from time to time or any other provisions under FTP/HBP for issuance of Advance Authorization and regularization of the case.

Manual Cases for Personal Hearing held on 28/04/2023.

Case No. A-01
Meeting No. NC/3/MEET/Apr/202324/1
Date 28/04/2023
Firm’s Name M/s Arch Pharmalabs Limited
HQ F. No. 01/82/050/01264/AM19/DES-III
01/82/050/01263/AM19/DES-III
01/82/050/01251/AM19/DES-III
01/82/050/01249/AM19/DES-III
01/82/050/01260/AM19/DES-III
01/82/050/01035/AM20/DES-III
RLA F. No. 03/94/040/00126/AM19
03/94/040/00160/AM19
03/94/040/00141/AM19
03/94/040/00162/AM19
03/94/040/00158/AM19
03/94/040/00888/AM20
Advance Authorization No. and 0310822660 dated 27.07.2018, 0310822659 dated 27.07.2018
Date 0310822729 dated 31.07.2018, 0310822732 dated 31.07.2018
0310822734 dated 31.07.2018, 0310834332 dated 20.01.2020
Subject Request of M/s Arch Pharma Labs Limited for fixation of adhoc norms with
the description of Export Product “3a-Hydroxy-7-keto-5b-cholan-24-oic acid
(IP-5)” against Advance Authorization No.0310822660 dated 27.07.2018,
0310822659<br>dated<br>27.07.2018,<br>0310822729<br>dated<br>31.07.2018,
0310822732 dated 31.07.2018, 0310822734 dated 31.07.2018 and
0310834332 dated 20.01.2020
Decision : Shri Ashish Ujagare, Technical Director, Shri Sanjay Dhyalter and Shri Parth
V. had attended the Personal Hearing and explained firm’s case. The
Committee heard the explanation of Representatives of the firm and after
deliberation, firm was requested to furnish revised application as per
Annexure to Appendix 4E with justification alongwith stepwise processing
with wastage.
Case No. A-02
Meeting No. NC/3/MEET/Apr/202324/1
Date 28/04/2023
Firm’s Name M/s Arch Pharmalabs Limited
HQ F. No. HQRNORMREVIW00006595/AM23/DES-III<br>(Earlier F. No.01/82/050/001218/AM19/DES-III)
RLA F. No. 03/94/040/00142/AM19
Advance Authorization No. and Date 0310822704 dated 30.07.2018
Subject Request of M/s Arch Pharma Labs Limited for fixation of adhoc<br>norms against Advance Authorization No.0310822704 dated<br>30.07.2018
Decision : Shri Ashish Ujagare, Technical Director, Shri Sanjay Dhyalter<br>and Shri Parth V. had attended the Personal Hearing and<br>explained firm’s case. The Committee heard the explanation of<br>Representatives of the firm and after deliberation, firm was<br>requested to furnish revised application as per Annexure to<br>Appendix 4Ewith justification alongwith stepwise processing<br>withwastage.
MeetingNo:NC/3/MEET/Apr/202324/1<br>Date:28/04/2023 CaseNo:3/NC/3/MEET/Mar/202223/23<br>HQFileNumber: 018205000763AM20<br>RAFileNumber:<br>052404000375AM20<br>LicenseNumber:<br>0510412231<br>Dateof<br>AuthorisationIssu<br>ed:<br>23/10/2019<br>OfficeofIssue:<br>Office of the Additional Director General of Foreign Trade, CLA Delhi<br>IEC:<br>0588068624 MeetingNo:NC/3/MEET/Apr/202324/1<br>Date:28/04/2023 CaseNo:3/NC/3/MEET/Mar/202223/23<br>HQFileNumber: 018205000763AM20<br>RAFileNumber:<br>052404000375AM20<br>LicenseNumber:<br>0510412231<br>Dateof<br>AuthorisationIssu<br>ed:<br>23/10/2019<br>OfficeofIssue:<br>Office of the Additional Director General of Foreign Trade, CLA Delhi<br>IEC:<br>0588068624
Name: MENTHA AND ALLIED PRODUCTS PRIVATE LIMITED
Address: 309-311,3RDFLOOR,PRAGATI TOWER, NEWDELHI,110008.
PIN: 110008
TypeofLicense: Advance Licence with AU Condition
ApplicationBasis: Export Order
StatusofExporter: Merchant Cum Manufacturer Exporter
ExporterType: PrivateLimited
ExportProduct<br>Group: Chemical and Allied Products
CIFValueofthe<br>License: 10449199
CIFFCC: 144725
FOBValue: 12016580
FOBFCC: 166434
Decision : Shri Harshvardhan Nanda, Director, Shri Suresh Chandra Dhyani, General Manager and Shri<br>Arun Khetan had attended the Personal Hearing and explained firm’s case. The Committee heard<br>the explanation of Representatives of the firm and after deliberation it has been decided tocall<br>for following information/documents from the firm:-<br>I.<br>Since details of import and export are vogue in nature provide suitable<br>documents for clarification.<br>II.<br>Also, COA of import only indicates Aldehyde content and not complete COA.<br>Provide complete COA of import items.<br>III.<br>Percentage net content of (i) Orange Aldehyde (ii) D Limonene and (iii) Orange<br>Oil 10X in import.
MeetingNo:NC/3/MEET/Apr/202324/1 MeetingNo:NC/3/MEET/Apr/202324/1 Date:28/04/2023 CaseNo:4/NC/3/MEET/Mar/202223/23
HQFileNumber: 018205000947AM20
RAFileNumber: 052404000601AM20
LicenseNumber: 0510413159
Dateof<br>AuthorisationIssue<br>d: 01/01/2020
OfficeofIssue: Office of the Additional Director General of Foreign Trade, CLA Delhi
IEC: 0588068624
Name: MENTHA AND ALLIED PRODUCTS PRIVATE LIMITED
Address: 309-311,3RDFLOOR,PRAGATI TOWER, NEW DELHI,110008.
PIN: 110008
TypeofLicense: Advance License with AU Condition
ApplicationBasis: ExportOrder
StatusofExporter: Merchant Cum Manufacturer Exporter
ExporterType: PrivateLimited
ExportProduct<br>Group: Chemical and Allied Products
CIFValueofthe<br>License: 75372639
CIFFCC: 1048298
FOBValue: 86679444
FOBFCC: 1205555
Decision : Shri Harshvardhan Nanda, Director, Shri Suresh Chandra Dhyani, General Manager and Shri<br>Arun Khetan had attended the Personal Hearing and explained firm’s case. The Committee<br>heard the explanation of Representatives of the firm and after deliberation it has been decided to<br>call for following information/documents from the firm:-<br>I.<br>Since details of import and export are vogue in nature provide suitable<br>documents for clarification.<br>II.<br>Also, COA of import only indicates Aldehyde content and not complete COA.<br>Provide complete COA of import items.<br>III.<br>Percentage net content of (i) Orange Aldehyde (ii) D Limonene and (iii) Orange<br>Oil 10X in import.

Verbatim extracted text (OCR/PDF). Older scans and tables may show extraction artifacts — verify against the original for anything you act on.

Analysis

No analysis has been generated for this document yet.

Citation copied